רווח תפעולי לפני פחת: livanova.com (LIVN)

Production optimization through a network of certified partners minimizes supplier dependency for LivaNova PLC (LIVN). Leadership in neuromodulation and demand for implants ensure a steady cash flow. Shunting systems and nerve stimulation devices for clinics generate revenue. The cash EBITDA trend captures these processes, while 296.53 reflects the current state of the parameter, helping to assess the risk of overpaying for the asset.
פילוחי נתונים אנליטיים מרוכזים עבור LivaNova (LIVN)

This indicator determines the real cash efficiency of operating activities, excluding accounting adjustments and inflationary distortions to assess the true value of the business. By analyzing the EBITDA snapshot, an investor can see the cash flow stability, which in the case of LivaNova PLC (LIVN) is supported by steady demand for high-tech neuromodulation systems and cardiac surgery equipment across an expanding network of clinics.